Q2 FY2026 EarningsQ2 FY26 results beat consensus on profitability despite zero revenue in the pre-commercial phase: Normalized EPS of -$0.09 was significantly better than the -$0.50 expected, while net loss of $9.4M outperformed the $18.8M expected loss. Engineering progress, including NRC approval of the PIE methodology, alongside updated unit economics raising lifetime revenue per plant to $2.7B (+28.6% vs. prior), highlights improving long-term commercial value. Liquidity remains robust with $283.4M in cash, supporting a low cash burn strategy as the company advances towards 2030s deployment.